Literature DB >> 9699897

Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia.

R F Carmena-Ramon1, J M Ordovas, J F Ascaso, J Real, M A Priego, R Carmena.   

Abstract

We have examined the apo AI - 75 (G/A) and apo AI + 83(MspI +/-) polymorphisms at the APOA1 gene locus for associations with plasma lipid levels and response to an NCEP-I diet in 69 (44 women, 25 men) heterozygotes for familial hypercholesterolemia (FH). Subjects were studied at baseline (after consuming for one month a diet with 35%, fat, 10% saturated, and 300 mg/day cholesterol) and after 3 months of an NCEP-I diet. No gender-related differences for any of the lipid variables examined were found and the data were analyzed for men and women combined. For the apo AI - 75 (G/A) polymorphism, there were 51 G/G and 18 G/A subjects. At baseline, G/A subjects showed significantly lower total cholesterol (p = 0.0036), and LDL-C (p = 0.0023), and apo B (p = 0.0209), than G/G individuals, but no differences were found for HDL-C, triglycerides and VLDL-C values. Following the NCEP-I diet these genotype-related differences remained significant for total and LDL-C. The MspI (-) allele at the apo AI + 83 polymorphism was detected in the heterozygous state in five subjects and its presence was not associated with altered baseline lipids nor with dietary response to the NCEP-I diet. Our results suggest that FH subjects carrying the A allele at the apoAI - 75 (G/A) polymorphism have significantly lower total and LDL-C and apo B baseline levels but respond to a low-fat diet with similar reductions in total and LDL-C when compared with homozygotes for the G allele at this polymorphic site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699897     DOI: 10.1016/s0021-9150(98)00064-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.

Authors:  George V Z Dedoussis; Sandy Maumus; John Skoumas; Despoina M Choumerianou; Christos Pitsavos; Christodoulos Stefanadis; Sophie Visvikis-Siest
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

3.  Association of SNP rs5069 in APOA1 with Benign Breast Diseases in a Mexican Population.

Authors:  Carolina Domínguez-Díaz; María Cristina Morán-Moguel; Rosa Elena Navarro-Hernandez; Rebeca Romo-Vázquez; Adriana Patricia Mendizabal-Ruiz
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

4.  The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.

Authors:  Robert Block; James Corsetti; Ilan Goldenberg; Gabriel Vorobiof; Scott McNitt; Daniel Ryan; Wojciech Zareba; Arthur J Moss
Journal:  Heart Int       Date:  2009-06-30

5.  Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.

Authors:  Manjusha Dixit; Gourdas Choudhuri; Rajan Saxena; Balraj Mittal
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

6.  Treatment of dyslipidemia: genetic interactions with diet and drug therapy.

Authors:  J M Ordovas; E J Schaefer
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

7.  ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties.

Authors:  Ali I Albahrani; Jannete J Usher; Mohammed Alkindi; Eileen Marks; L Ranganath; Said Al-yahyaee
Journal:  Lipids Health Dis       Date:  2007-08-06       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.